Treace Medical Concepts Statistics
Total Valuation
TMCI has a market cap or net worth of $452.29 million. The enterprise value is $445.88 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TMCI has 62.90 million shares outstanding. The number of shares has increased by 1.15% in one year.
| Current Share Class | 62.90M |
| Shares Outstanding | 62.90M |
| Shares Change (YoY) | +1.15% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 24.21% |
| Owned by Institutions (%) | 50.39% |
| Float | 47.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.13 |
| Forward PS | 1.91 |
| PB Ratio | 4.30 |
| P/TBV Ratio | 5.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.50, with a Debt / Equity ratio of 0.66.
| Current Ratio | 4.50 |
| Quick Ratio | 3.25 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.95 |
Financial Efficiency
Return on equity (ROE) is -45.73% and return on invested capital (ROIC) is -17.59%.
| Return on Equity (ROE) | -45.73% |
| Return on Assets (ROA) | -14.56% |
| Return on Invested Capital (ROIC) | -17.59% |
| Return on Capital Employed (ROCE) | -30.26% |
| Revenue Per Employee | $441,969 |
| Profits Per Employee | -$111,088 |
| Employee Count | 477 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 1.13 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +64.16% in the last 52 weeks. The beta is 0.80, so TMCI's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | +64.16% |
| 50-Day Moving Average | 7.65 |
| 200-Day Moving Average | 7.28 |
| Relative Strength Index (RSI) | 49.03 |
| Average Volume (20 Days) | 518,853 |
Short Selling Information
The latest short interest is 2.43 million, so 3.86% of the outstanding shares have been sold short.
| Short Interest | 2.43M |
| Short Previous Month | 2.24M |
| Short % of Shares Out | 3.86% |
| Short % of Float | 5.10% |
| Short Ratio (days to cover) | 6.14 |
Income Statement
In the last 12 months, TMCI had revenue of $210.82 million and -$52.99 million in losses. Loss per share was -$0.85.
| Revenue | 210.82M |
| Gross Profit | 169.18M |
| Operating Income | -52.25M |
| Pretax Income | -63.68M |
| Net Income | -52.99M |
| EBITDA | -44.28M |
| EBIT | -52.25M |
| Loss Per Share | -$0.85 |
Full Income StatementBalance Sheet
The company has $76.09 million in cash and $69.36 million in debt, giving a net cash position of $6.73 million or $0.11 per share.
| Cash & Cash Equivalents | 76.09M |
| Total Debt | 69.36M |
| Net Cash | 6.73M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | 105.34M |
| Book Value Per Share | 1.67 |
| Working Capital | 116.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$25.75 million and capital expenditures -$11.21 million, giving a free cash flow of -$36.96 million.
| Operating Cash Flow | -25.75M |
| Capital Expenditures | -11.21M |
| Free Cash Flow | -36.96M |
| FCF Per Share | -$0.59 |
Full Cash Flow StatementMargins
Gross margin is 80.25%, with operating and profit margins of -24.78% and -25.13%.
| Gross Margin | 80.25% |
| Operating Margin | -24.78% |
| Pretax Margin | -25.13% |
| Profit Margin | -25.13% |
| EBITDA Margin | -21.00% |
| EBIT Margin | -24.78% |
| FCF Margin | n/a |
Dividends & Yields
TMCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.15% |
| Shareholder Yield | -1.15% |
| Earnings Yield | -11.71% |
| FCF Yield | -8.17% |
Analyst Forecast
The average price target for TMCI is $9.18, which is 27.68% higher than the current price. The consensus rating is "Hold".
| Price Target | $9.18 |
| Price Target Difference | 27.68% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMCI has an Altman Z-Score of 2.26 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.26 |
| Piotroski F-Score | 3 |